115 related articles for article (PubMed ID: 11682199)
21. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.
Rommel O; Dillner J; Fligge C; Bergsdorf C; Wang X; Selinka HC; Sapp M
J Med Virol; 2005 Jan; 75(1):114-21. PubMed ID: 15543569
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo.
Malboeuf CM; Simon DA; Lee YE; Lankes HA; Dewhurst S; Frelinger JG; Rose RC
Vaccine; 2007 Apr; 25(17):3270-6. PubMed ID: 17293010
[TBL] [Abstract][Full Text] [Related]
23. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions.
Zhao KN; Hengst K; Liu WJ; Liu YH; Liu XS; McMillan NA; Frazer IH
Virology; 2000 Jul; 272(2):382-93. PubMed ID: 10873782
[TBL] [Abstract][Full Text] [Related]
24. Porcine epidemic diarrhea virus uses cell-surface heparan sulfate as an attachment factor.
Huan CC; Wang Y; Ni B; Wang R; Huang L; Ren XF; Tong GZ; Ding C; Fan HJ; Mao X
Arch Virol; 2015 Jul; 160(7):1621-8. PubMed ID: 25896095
[TBL] [Abstract][Full Text] [Related]
25. Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Buck CB; Pastrana DV; Lowy DR; Schiller JT
Methods Mol Med; 2005; 119():445-62. PubMed ID: 16350417
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
[TBL] [Abstract][Full Text] [Related]
27. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
28. Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions.
Liu Y; Frazer IH; Liu WJ; Liu XS; McMillan N; Zhao KN
Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):150-6. PubMed ID: 11499923
[TBL] [Abstract][Full Text] [Related]
29. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
Guibinga GH; Miyanohara A; Esko JD; Friedmann T
Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
[TBL] [Abstract][Full Text] [Related]
30. Chimeric papillomavirus-like particles.
Müller M; Zhou J; Reed TD; Rittmüller C; Burger A; Gabelsberger J; Braspenning J; Gissmann L
Virology; 1997 Jul; 234(1):93-111. PubMed ID: 9234950
[TBL] [Abstract][Full Text] [Related]
31. The interaction of heparin sulfate and adeno-associated virus 2.
Qiu J; Handa A; Kirby M; Brown KE
Virology; 2000 Mar; 269(1):137-47. PubMed ID: 10725206
[TBL] [Abstract][Full Text] [Related]
32. Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.
Bousarghin L; Touzé A; Yvonnet B; Coursaget P
J Med Virol; 2004 Jul; 73(3):474-80. PubMed ID: 15170645
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions.
Selinka HC; Giroglou T; Sapp M
Virology; 2002 Aug; 299(2):279-287. PubMed ID: 12202231
[TBL] [Abstract][Full Text] [Related]
34. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies.
Christensen ND; Höpfl R; DiAngelo SL; Cladel NM; Patrick SD; Welsh PA; Budgeon LR; Reed CA; Kreider JW
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2271-6. PubMed ID: 7521393
[TBL] [Abstract][Full Text] [Related]
35. Carrageenan is a potent inhibitor of papillomavirus infection.
Buck CB; Thompson CD; Roberts JN; Müller M; Lowy DR; Schiller JT
PLoS Pathog; 2006 Jul; 2(7):e69. PubMed ID: 16839203
[TBL] [Abstract][Full Text] [Related]
36. Non-human papillomaviruses for gene delivery in vitro and in vivo.
Bayer L; Gümpel J; Hause G; Müller M; Grunwald T
PLoS One; 2018; 13(6):e0198996. PubMed ID: 29912929
[TBL] [Abstract][Full Text] [Related]
37. Studies of Echovirus 5 interactions with the cell surface: heparan sulfate mediates attachment to the host cell.
Israelsson S; Gullberg M; Jonsson N; Roivainen M; Edman K; Lindberg AM
Virus Res; 2010 Aug; 151(2):170-6. PubMed ID: 20466025
[TBL] [Abstract][Full Text] [Related]
38. Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles.
Rose RC; Bonnez W; Da Rin C; McCance DJ; Reichman RC
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2445-9. PubMed ID: 8077946
[TBL] [Abstract][Full Text] [Related]
39. Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor.
Culp TD; Budgeon LR; Christensen ND
Virology; 2006 Mar; 347(1):147-59. PubMed ID: 16376962
[TBL] [Abstract][Full Text] [Related]
40. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
